Mirum Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $185,721 | $176,243 | $159,882 | $148,932 |
Gross Profit | 150,549 | 145,895 | 131,002 | 120,594 |
EBITDA | -31,733 | -11,367 | -779,190 | 4,709 |
EBIT | -38,622 | -18,303 | -786,064 | -1,365 |
Net Income | -40,766 | -67,227 | -790,155 | -5,730 |
Net Change In Cash | 185,721 | 176,243 | 159,882 | 148,932 |
Free Cash Flow | -5,616 | -273,702 | -229,427 | 5,467 |
Cash | 243,188 | 330,728 | 324,907 | 296,683 |
Basic Shares | 66,049 | 63,374 | 58,851 | 50,198 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $521,312 | $336,888 | $186,374 | $77,062 |
Gross Profit | 420,728 | 255,245 | 139,335 | 64,688 |
EBITDA | 17,206 | -48,972 | -136,490 | -122,854 |
EBIT | -7,038 | -72,601 | -147,319 | -126,092 |
Net Income | -23,363 | -87,942 | -163,415 | -135,665 |
Net Change In Cash | 521,312 | 336,888 | 186,374 | 77,062 |
Cost of Revenue | -3,349 | |||
Free Cash Flow | 54,873 | 9,332 | -91,053 | -120,414 |
Cash | 296,683 | 222,503 | 286,326 | 28,003 |
Basic Shares | 50,198 | 47,523 | 40,885 | 33,982 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.87 |
2026-06-30 | -$0.80 |
2026-03-31 | -$1.08 |
2025-12-31 | -$0.12 |